Akrivis Technologies is a biopharmaceutical company committed to the early detection, diagnosis, and treatment of serious and life-threatening diseases. Its Z–TECT technology platform provides detection and quantification of biomolecules down to the zeptomole range, therefore allowing the detection of individual molecules.